However, numerous mechanisms of how MetS affected pathological features and survival outcomes have been proposed but fail to elaborate at the molecular level, involving insulin-like growth factor (IGF) axis, pro-inflammatory cytokines, circulating factors, angiogenesis, and other important aspects (10). The gene discussed is IGF1; the disease is metabolic syndrome.